Gene-Disorder Association · Article
Gene
TYMSOSTYMS Opposite Strand RNA
×
First reported
1979
Supporting publications
2
Approved treatment annotated
Association Review
In brief
The association between TYMSOS (TYMS Opposite Strand RNA) and Lung Non-Small Cell Carcinoma is reported, supported by a single source.
Sources
1
Clinical variants
0
Symptoms
0
Compounds
3
Trials
97of 3,042 via TYMSOS compounds
Publications
2
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources
1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
03
Lung Non-Small Cell Carcinoma
The disorder
6 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
04
Interventions
Therapeutics
3 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
05
Human studies
Clinical trials
3,042 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
2 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
07
Provenance
References & sources
5 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access